Itraconazole Dispersion In Polymer Matrix clinical trials
How each study uses Itraconazole Dispersion In Polymer Matrix is sorted by a rule, right about nine times in ten. Readers can ask us to read every study one by one.Ask us to read each study
Approvals
The first approval found in each region, with its record
- United States
- Not in FDA's approval records
- European Union
- Not in EMA's list of EU-wide authorisations
From FDA's Drugs@FDA and Purple Book (through openFDA) and the European Medicines Agency, files of Sept 2026 and 27 Oct 2026. National approvals in Europe and other countries are not included. How this is worked out
How studies write it
Studies that test it under each name
Name
- SUBA-itraconazole
- 4
Studies by the year they started
5 studies that test it; most in 2008 (1)
| Year | Studies |
|---|---|
| 2008 | 1 |
| 2015 | 1 |
| 2018 | 1 |
| 2021 | 1 |
| 2022 | 1 |
By phase
A phase 1/2 study counts in both.
What it is tested for
Each study’s main condition, where its own words name it, so a study counts once.
Who runs them
Industry 2 · Other 3
Anthony Joshua, FRACP (1) · University of Alabama at Birmingham (1) · Halcygen Pharmaceuticals Limited (1) · HedgePath Pharmaceuticals, Inc. (1) · George R Thompson (1)
Often tested with
Tested in the same studies.
Studies
Open first, then newest update. How each study uses Itraconazole Dispersion In Polymer Matrix is read from its arms, and is right about nine times in ten. Ask us to read each study. These are the studies that list it as an intervention; a search of ClinicalTrials.gov also finds studies that mention it only in a description, such as earlier treatment.
Testing it · 5
- Tamoxifen and SUBA-Itraconzole Combination Testing in Ovarian CancerActive, not recruitingPhase 1Anthony Joshua, FRACPNCT05156892Written as SUBA-itraconazole
- Endemic Mycoses Treatment With SUBA-itraconazole vs ItraconazoleCompletedPhase 2/3University of Alabama at BirminghamNCT03572049Written as SUBA itraconazole
- SUBA-Itraconazole Therapy for Coccidioidomycosis Refractory or Intolerant to FluconazoleWithdrawnPhase 2George R ThompsonNCT04809649Written as SUBA-itraconazole
- Study Comparing SUBA™-Itraconazole With SPORANOX® (Itraconazole) in the Treatment of OnychomycosisCompletedPhase 2Halcygen Pharmaceuticals LimitedNCT00791219Written as SUBA-itraconazole
- Open-label Trial of SUBA™-Itraconazole (SUBA-Cap) in Subjects With Basal Cell Carcinoma Nevus Syndrome (BCCNS)CompletedPhase 2HedgePath Pharmaceuticals, Inc.NCT02354261Written as SUBA-Itraconazole